116 related articles for article (PubMed ID: 18410999)
21. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
Latonen L; Taya Y; Laiho M
Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
[TBL] [Abstract][Full Text] [Related]
22. Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors.
Aizu W; Belinsky GS; Flynn C; Noonan EJ; Boes CC; Godman CA; Doshi B; Nambiar PR; Rosenberg DW; Giardina C
Biochem Pharmacol; 2006 Oct; 72(8):981-91. PubMed ID: 16949053
[TBL] [Abstract][Full Text] [Related]
23. Role of nuclear factor-kappaB and P53 in radioadaptive response in Chang live cells.
Yuan D; Pan Y; Zhang J; Shao C
Mutat Res; 2010 Jun; 688(1-2):66-71. PubMed ID: 20307555
[TBL] [Abstract][Full Text] [Related]
24. p53-dependent adaptive responses in human cells exposed to space radiations.
Takahashi A; Su X; Suzuki H; Omori K; Seki M; Hashizume T; Shimazu T; Ishioka N; Iwasaki T; Ohnishi T
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1171-6. PubMed ID: 20729005
[TBL] [Abstract][Full Text] [Related]
25. The role of nitric oxide radicals in removal of hyper-radiosensitivity by priming irradiation.
Edin NJ; Sandvik JA; Vollan HS; Reger K; Görlach A; Pettersen EO
J Radiat Res; 2013 Nov; 54(6):1015-28. PubMed ID: 23685670
[TBL] [Abstract][Full Text] [Related]
26. Induction of radioresistance to accelerated carbon-ion beams in recipient cells by nitric oxide excreted from irradiated donor cells of human glioblastoma.
Matsumoto H; Hayashi S; Hatashita M; Shioura H; Ohtsubo T; Kitai R; Ohnishi T; Yukawa O; Furusawa Y; Kano E
Int J Radiat Biol; 2000 Dec; 76(12):1649-57. PubMed ID: 11133047
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction.
D'Arcy P; Ryan BA; Brodin B
Cancer Lett; 2009 Mar; 275(2):285-92. PubMed ID: 19081178
[TBL] [Abstract][Full Text] [Related]
28. Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin.
Efeyan A; Ortega-Molina A; Velasco-Miguel S; Herranz D; Vassilev LT; Serrano M
Cancer Res; 2007 Aug; 67(15):7350-7. PubMed ID: 17671205
[TBL] [Abstract][Full Text] [Related]
29. Dose response of soft X-ray-induced bystander cell killing affected by p53 status.
Tomita M; Maeda M; Kobayashi K; Matsumoto H
Radiat Res; 2013 Feb; 179(2):200-7. PubMed ID: 23289390
[TBL] [Abstract][Full Text] [Related]
30. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines.
Chène P; Fuchs J; Bohn J; García-Echeverría C; Furet P; Fabbro D
J Mol Biol; 2000 May; 299(1):245-53. PubMed ID: 10860736
[TBL] [Abstract][Full Text] [Related]
31. Effects of low and high LET radiations on bystander human lung fibroblast cell survival.
Baskar R; Balajee AS; Geard CR
Int J Radiat Biol; 2007 Aug; 83(8):551-9. PubMed ID: 17613128
[TBL] [Abstract][Full Text] [Related]
32. Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma.
Van Maerken T; Speleman F; Vermeulen J; Lambertz I; De Clercq S; De Smet E; Yigit N; Coppens V; Philippé J; De Paepe A; Marine JC; Vandesompele J
Cancer Res; 2006 Oct; 66(19):9646-55. PubMed ID: 17018622
[TBL] [Abstract][Full Text] [Related]
33. A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions.
Lundholt BK; Heydorn A; Bjørn SP; Praestegaard M
Assay Drug Dev Technol; 2006 Dec; 4(6):679-88. PubMed ID: 17199506
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression.
Cressey R; Pimpa S; Tontrong W; Watananupong O; Leartprasertsuke N
Cancer Lett; 2006 Feb; 233(2):232-9. PubMed ID: 15921850
[TBL] [Abstract][Full Text] [Related]
35. A novel application for murine double minute 2 antagonists: the p53 tumor suppressor network also controls angiogenesis.
Binder BR
Circ Res; 2007 Jan; 100(1):13-4. PubMed ID: 17204660
[No Abstract] [Full Text] [Related]
36. ROS and p53 in regulation of UVB-induced HDM2 alternative splicing.
Tong L; Wu S
Photochem Photobiol; 2015; 91(1):221-4. PubMed ID: 24986024
[TBL] [Abstract][Full Text] [Related]
37. A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097.
Jeay S; Gaulis S; Ferretti S; Bitter H; Ito M; Valat T; Murakami M; Ruetz S; Guthy DA; Rynn C; Jensen MR; Wiesmann M; Kallen J; Furet P; Gessier F; Holzer P; Masuya K; Würthner J; Halilovic E; Hofmann F; Sellers WR; Graus Porta D
Elife; 2015 May; 4():. PubMed ID: 25965177
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide-mediated inhibition of Hdm2-p53 binding.
Schonhoff CM; Daou MC; Jones SN; Schiffer CA; Ross AH
Biochemistry; 2002 Nov; 41(46):13570-4. PubMed ID: 12427017
[TBL] [Abstract][Full Text] [Related]
39. Core modification of substituted piperidines as novel inhibitors of HDM2-p53 protein-protein interaction.
Pan W; Lahue BR; Ma Y; Nair LG; Shipps GW; Wang Y; Doll R; Bogen SL
Bioorg Med Chem Lett; 2014 Apr; 24(8):1983-6. PubMed ID: 24656661
[TBL] [Abstract][Full Text] [Related]
40. Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells.
Sui X; Shin S; Zhang R; Firozi PF; Yang L; Abbruzzese JL; Reddy SA
Oncogene; 2009 Feb; 28(5):709-20. PubMed ID: 19029954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
